Results 231 to 240 of about 56,162 (258)

JAK Inhibitors

2021
openaire   +1 more source

Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis

Cancers, 2020
Andrew T Kuykendall, Nathan P Horvat, Garima Pandey   +2 more
exaly  

Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?

International Journal of Molecular Sciences, 2021
Przemysław Kotyla, Bartosz Wnuk, Asiful Islam   +2 more
exaly  

Management of Alopecia Areata With Topical JAK Inhibitor Therapy: An Evidence-Based Review

Journal of Cutaneous Medicine and Surgery, 2023
Abrahim Abduelmula, Asfandyar Mufti, Jenna Mistry   +2 more
exaly  

The use of JAK inhibitors and the impact of comorbidities

Rheumatology, 2023
Fabiola Atzeni, Alessandra Alciati
openaire   +2 more sources

The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells

International Journal of Molecular Sciences, 2020
Jung Eun Kim, Kwan Ho Jeong, Hoon Kang
exaly  

Understanding JAK inhibitor toxicity

Journal of the American Academy of Dermatology
Athira, Sivadas, Kevin W, Byram, Manuel, Valdebran, Tyler, Beck   +3 more
openaire   +2 more sources

JAK kinase inhibitors

Drug Discovery Today, 2004
Christopher Burns, Andrew Wilks, Stephen Su   +2 more
openaire   +1 more source

PAN-JAK Inhibitors/Non-selective JAK Inhibitors

Salih Levent Çınar, Fatih Can Aba
openaire   +1 more source

3-O-methylthespesilactam, a new small-molecule anticancer pan-JAK inhibitor against A2058 human melanoma cells

Biochemical Pharmacology, 2013
Min-Yi Li, Ralf Buettner, Lucy Liu
exaly